chartexchange

PASG
Passage Bio, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:38 PM EST
4.04USD-4.265%(-0.18)14,526
After-hoursNov 18, 2026 4:00:30 PM EST
4.135USD+2.351%(+0.095)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Philadelphia, PA, USA
Previous Close
$4.22
Beta
2.03
52-Week High
$20.00 2026-01-09
52-Week Low
$3.29 2026-06-25
SMA 50
$4.09
SMA 200
$5.74
Avg. Vol 10D
20,412
Avg. Vol 30D
17,286
Avg. Vol 90D
22,515
Relative Vol
0.84
2.97M
1.5500%
258
Jul 14, 2025 · 1-for-20 (reverse)
PASG Profile

passage bio, inc., a genetic medicines company, develops transformative therapies for rare monogenic central nervous system (cns) diseases. the company develops pbgm01, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional glb1 gene encoding lysosomal acid beta-galactosidase (ãŸ-gal) for infantile gm1; pbft02, which utilizes an aav1 capsid to deliver to the brain a functional granulin, or grn, gene encoding progranulin for the treatment of ftd caused by a deficiency of progranulin; and pbkr03, which utilizes a proprietary, aavhu68 capsid to deliver to the brain and peripheral tissues a functional galc gene encoding the hydrolytic enzyme galactosylceramidase, for infantile krabbe disease. it has a strategic research collaboration with the trustees of the university of pennsylvania's gene therapy program; and collaboration agreement, and a development services and clinical supply agreement with catalent maryland, inc. the company was fou

PASG Performance
PeriodPriceDateChangeBeta
1W4.002026-11-11+0.25%3.709
1M3.582026-10-19+12.01%0.020
3M4.522026-08-18-11.28%0.145
6M5.122026-05-18-21.68%0.562
1Y8.522025-11-18-52.93%2.031
2Y9.422024-11-18-57.43%—
5Y164.002021-11-18-97.56%1.610
PASG Stock Summary

Passage Bio, Inc. Common Stock (NASDAQ:PASG) stock price today is $4.01, and today's volume is 14,526. PASG is down 4.976% today. The 30 day average volume is 17,286. PASG market cap is $12.90M with 3.22M shares outstanding.